Pharma-Bio Serv (PBSV) Retained Earnings (2010 - 2026)

Pharma-Bio Serv (PBSV) has reported Retained Earnings for 16 consecutive years, with $9.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Retained Earnings fell 15.42% year-over-year to $9.1 million; the trailing twelve-month figure through Apr 2026 stood at $9.1 million (down 15.42% YoY), and the FY2025 full-year result was $10.5 million, down 14.74% from the prior year.
• Retained Earnings rose to $9.1 million in Q2 2026 per PBSV's latest filing, from $8.8 million in the prior quarter.
• Across five years, Retained Earnings topped out at $16.3 million in Q1 2022 and bottomed at $8.8 million in Q1 2026.
• Historically, Retained Earnings has averaged $12.9 million across 5 years, with a median of $12.8 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Retained Earnings sank 33.15% in 2022, then fell 1.28% in 2023.
• Over 5 years, Retained Earnings stood at $15.3 million in 2022, then decreased by 2.71% to $14.9 million in 2023, then dropped by 16.83% to $12.4 million in 2024, then retreated by 14.74% to $10.5 million in 2025, then slipped by 13.78% to $9.1 million in 2026.
• According to Business Quant data, Retained Earnings over the past three periods registered $9.1 million, $8.8 million, and $10.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.